{"id":"W4210298192","doi":"10.1016/j.esmoop.2022.100403","title":"Managing hematological cancer patients during the COVID-19 pandemic: an ESMO-EHA Interdisciplinary Expert Consensus","year":2022,"lang":"en","type":"article","venue":"ESMO Open","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Cilag; Janssen Pharmaceuticals; Chugai Pharmaceutical; AstraZeneca; Genentech; MorphoSys; PharmaMar; Daiichi Sankyo Europe; European Society for Medical Oncology; Deutsche Krebshilfe; Pfizer; José Carreras Leukämie-Stiftung; Shionogi; British Society for Haematology; National Institute for Health and Care Research; Bayer; Astellas Pharma; Celltrion; SkylineDx; Sanofi-Aventis Deutschland; BeiGene; Sanofi; TG Therapeutics; Medac; Ipsen; Jazz Pharmaceuticals; Regeneron Pharmaceuticals; Meso Scale Diagnostics; Helsinn; Takeda Pharmaceutical Company; Novartis Pharma; AbbVie; AOP Orphan; Bundesministerium für Bildung und Forschung; EUSA Pharma; Merck KGaA; Incyte; Servier; Gilead Sciences; Celgene; Novartis; GlaxoSmithKline; Eli Lilly and Company; Bristol-Myers Squibb; Deutsche Forschungsgemeinschaft; Roche; Sierra Oncology; Galecto; Astellas Pharma US; Boehringer Ingelheim; Amgen","keywords":"Pandemic; Coronavirus disease 2019 (COVID-19); Medicine; Consensus conference; MEDLINE; Family medicine; 2019-20 coronavirus outbreak; Intensive care medicine; Political science; Internal medicine; Pathology; Disease; Law","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006152854,0.0001947354,0.0003920857,0.00009335663,0.001288801,0.00006674205,0.0005852773,0.00006747458,0.00229832],"category_scores_gemma":[0.0002302104,0.0001348664,0.00007988198,0.0002218772,0.0001209721,0.00009673004,0.002469257,0.0005615101,0.0000158968],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001046073,"about_ca_system_score_gemma":0.0006248655,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01100427,"about_ca_topic_score_gemma":0.002324363,"domain_scores_codex":[0.9980015,0.0003147658,0.0003610058,0.0004712071,0.000392197,0.0004593573],"domain_scores_gemma":[0.998515,0.0002637984,0.0001373619,0.0005267389,0.00005275997,0.0005044042],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002129903,0.0004830706,0.9539415,0.0002344479,0.00009402388,0.0007079642,0.0144649,0.0001389011,0.00008057916,0.0001645544,0.02162764,0.005932463],"study_design_scores_gemma":[0.007355665,0.001287555,0.8097555,0.0001628106,0.00008614488,0.001142728,0.01230731,0.0005396631,0.0001071502,0.001483157,0.1652116,0.0005606965],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.928919,0.0002246009,0.0000119956,0.06756864,0.0004114483,0.00133663,0.00004384316,0.0001118326,0.001372032],"genre_scores_gemma":[0.9645471,0.00006662672,0.00005087146,0.03376514,0.0001301277,0.0004023339,0.0000560991,0.00003010891,0.0009515836],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1441861,"threshold_uncertainty_score":0.9986137,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1554210049298026,"score_gpt":0.4771415186154561,"score_spread":0.3217205136856536,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}